Moleculin Biotech grants CFO Jonathan Foster 260,000 stock options and 260,000 restricted stock units
MBRX•Moleculin Biotech granted CFO Jonathan P. Foster 260,000 stock options and 260,000 restricted stock units on October 15, 2026.
1. Equity awards
Moleculin Biotech granted Chief Financial Officer Jonathan P. Foster 260,000 stock options and 260,000 restricted stock units on October 15, 2026.
